Hjelmstrom et al. (92) |
1998 |
B cell-independent demyelination in myelin oligodendrocyte glycoprotein (MOG)-induced EAE mice |
Litzenburger et al. (89) |
1998 |
MOG-specific B cells accelerate and exacerbate EAE, but are not able to induce spontaneous disease or demyelination without induced EAE |
Stefferl et al. (87) |
1999 |
Major histocompatibility complex (MHC) and MHC-linked effects can influence the antibody response and thereby disease severity in MOG-induced EAE |
Lyons et al. (90) |
1999 |
B-cell-deficient mice immunized with MOG35–55 induced EAE but not mice immunized with recombinant full-length MOG |
Forsthuber et al. (88) |
2001 |
MOG peptide 97–108 is the immunodominant human leukocyte antigen (HLA)-DR4-restricted T cell epitope in transgenic mice and is presented by human B cells expressing HLA-DR4 (DRB1*0401) |
Lyons et al. (91) |
2002 |
MOG-specific B cells and serum reconstitute the ability for inducing inflammatory EAE effects in B cell-deficient mice |
Fillatreau et al. (93) |
2002 |
IL-10 production of B cells regulate type 1 immunity and play a key role in EAE recovery |
Svensson et al. (96) |
2002 |
B cell-deficient mice with different genetic backgrounds (C57BL/10 and DBA/1) immunized with MOG1–125 showed decreased demyelination but inflammation was not affected |
Bettelli et al. (97) |
2006 |
TCRMOG × IgHMOG mice develop severe EAE, with inflammatory lesions in the spinal cord and optic nerves |
Pollinger et al. (78) |
2009 |
Transgenic mice expressing MOG92–106 specific T cells expand endogenous MOG-specific B cells, producing conformational, (epitope independent) Abs, and enhancing demyelinating EAE in a relapsing-remitting EAE model |
Molnarfi et al. (94) |
2013 |
MOG-specific B cells play a critical role in the EAE pathogenesis due to its function as an antigen-presenting cells |
Parker Harp et al. (95) |
2015 |
B cells directly interact with dendritic cells and enhance CD4 driven EAE severity in mice |
Flach et al. (58) |
2016 |
MOG-specific B cells accelerate MOG T cell driven EAE inflammation and disease severity |